326-61-4
CAS 326-61-4
326-61-4 (CAS 326-61-4) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 23438.785714285714 nM | 7 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 326-61-4 used for in pharmaceutical contexts?
326-61-4 (CAS 326-61-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 326-61-4?
No adverse-event association or SIDER side-effect rows are rendered for 326-61-4 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 326-61-4 also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for 326-61-4.
What clinical phase is 326-61-4 in?
No phase 1-4 clinical development badge is rendered for 326-61-4 because the matched compound identifier rows do not contain a max-phase value.